Vyome Holdings, Inc
Vyome develops clinical-stage therapies for immuno-inflammatory conditions, leveraging a US-India innovation platform.
10-K/ASep 28Latest SEC filing
Aug 28Latest story
Sign inSign inVyome develops clinical-stage therapies for immuno-inflammatory conditions, leveraging a US-India innovation platform.